Cardiovasc Diabetol:睡眠时间可预测糖尿病患者的长期死亡率!

2022-05-05 Nebula MedSci原创

睡眠时间与2型糖尿病患者的全因和心血管疾病死亡率之间存在“J”型关联,睡眠时间为5-7小时时的死亡风险最低。

睡眠占据了大多数人一天中大约三分之一的时间。众所周知,睡眠对一个人的健康和幸福至关重要。既往研究显示,睡眠时间与死亡率有关。但是,既往探索睡眠时间是否能预测糖尿病患者随后的长期死亡率的研究有限。

本研究目的是在2型糖尿病(T2DM)患者中,评估代谢状态是否会影响基础睡眠时间与后续全因/心血管疾病 (CVD) 死亡风险之间的相关性。

该研究共纳入了12526位30岁及以上的T2DM患者,随访长达3年以上。通过计算机问卷调查睡眠时间。使用Cox比例风险模型评估睡眠时间与全因死亡率、扩大的CVD和非扩大的CVD死亡率的相关性。


睡眠时间与全因死亡率(a)、扩大CVD死亡率(b)和非扩大CVD死亡率(c)之间的相关性

在随访的10年时间中,共记录了2918例死亡,包括1328例CVD死亡和1590例非CVD死亡。睡眠时间与全因死亡率、扩大的CVD死亡率和非扩大的CVD死亡率之间存在“J”形相关性,睡眠时间为5-7小时的患者的死亡风险最低。


睡眠时间与死亡率相关性的亚组分析

全因死亡率的显著关节效应包括≥65岁睡眠时间超过或短于7小时(校正风险比[HR] 4.0)、糖尿病病史≥5年(1.6)、45岁前确诊糖尿病(1.69)、使用胰岛素(1.76)、收缩压/舒张压>130/85 mmHg(1.24)、甘油三酯≥150 mg/dL(1.38)、HbA1c≥7%(1.31)和体重指数<27 kg/m2。

总之,睡眠时间与2型糖尿病患者的全因和心血管疾病死亡率之间存在“J”型关联,睡眠时间为5-7小时时的死亡风险最低。睡眠时间与糖尿病持续时间存在显著的协同作用,但与年龄和肥胖具有拮抗作用。

 

原始出处:

Li, CI., Lin, CC., Liu, CS. et al. Sleep duration predicts subsequent long-term mortality in patients with type 2 diabetes: a large single-center cohort study. Cardiovasc Diabetol 21, 60 (2022). https://doi.org/10.1186/s12933-022-01500-0.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1761916, encodeId=d5261e6191686, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jul 26 15:43:54 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1939351, encodeId=4dd9193935166, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 21 09:43:54 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640136, encodeId=fcd5164013664, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Oct 11 15:43:54 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1475263, encodeId=10a214e5263a6, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu May 05 13:43:54 CST 2022, time=2022-05-05, status=1, ipAttribution=)]
    2022-07-26 docwu2019
  2. [GetPortalCommentsPageByObjectIdResponse(id=1761916, encodeId=d5261e6191686, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jul 26 15:43:54 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1939351, encodeId=4dd9193935166, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 21 09:43:54 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640136, encodeId=fcd5164013664, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Oct 11 15:43:54 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1475263, encodeId=10a214e5263a6, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu May 05 13:43:54 CST 2022, time=2022-05-05, status=1, ipAttribution=)]
    2022-06-21 quxin068
  3. [GetPortalCommentsPageByObjectIdResponse(id=1761916, encodeId=d5261e6191686, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jul 26 15:43:54 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1939351, encodeId=4dd9193935166, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 21 09:43:54 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640136, encodeId=fcd5164013664, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Oct 11 15:43:54 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1475263, encodeId=10a214e5263a6, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu May 05 13:43:54 CST 2022, time=2022-05-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1761916, encodeId=d5261e6191686, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jul 26 15:43:54 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1939351, encodeId=4dd9193935166, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 21 09:43:54 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640136, encodeId=fcd5164013664, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Oct 11 15:43:54 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1475263, encodeId=10a214e5263a6, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu May 05 13:43:54 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

相关资讯

JCEM:低风险生活方式和健康因素与糖尿病患者死亡和血管并发症风险的关系

该研究的结果表明,在预防和处理糖尿病相关不良结局方面,采取低风险的生活方式应被视为与实现理想的血压和血糖目标同等重要。

近34万人研究:睡个好觉防糖尿病!效果堪比大幅减重!

Diabetes Care:评估睡眠性状对糖化血红蛋白的因果作用:一项孟德尔随机化研究

亚太最新临床研究结果发布,糖尿病创新药物iGlarLixi降糖效果和安全性更优!

中国国家药品监督管理局(NMPA)已于2021年9月28日正式受理iGlarLixi的新药上市申请,期待尽早为中国糖尿病患者带来全新的降糖选择。

J Am Heart Assoc:糖尿病患者认知障碍与心血管事件的相关性分析

低认知评分是心血管疾病(CVD)的潜在危险因素,为评估认知指数评分与CVD预后的关联,研究人员收集了8772例REWIND研究中的 2型糖尿病患者数据,

喝酒脸红是能还是不能喝?反正研究显示,一喝酒就脸红,高血压风险可翻倍!

J Clin Hypertens:韩国成年人面部潮红变化与饮酒行为模式高血压之间的关系